About 3 months has passed since the CEO sent the investment proposal and then the valuation comparison to Tenaya Therapeutics. Clinical Trials site still shows January as the trial start date as of now. https://clinicaltrials.gov/ct2/show/NCT02928094?term=affirm&cond=Refractory+Angina&draw=2&rank=1 Not a peep from the company as far as I know to anyone, either publicly or privately, since the middle of August.